Published in Clinical Oncology Week, December 10th, 2007
"We analyzed the prevalence of CHEK2 1100delC in 763 breast cancer patients with a defined family history and 760 controls from the Stockholm region. The breast cancer patients originated from; a population-based cohort ( n = 452) and from a familial cancer clinic ( n = 311), the detailed family history was known in both groups. The variant was found in 2.9% of the familial cases from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.